RGD (ARG-GLY-ASP) coupled to (neuro)peptides

Use of a peptide compound, which comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, for the manufacture of an agent having biological activity preferably the compound is used for the manufac...

Full description

Saved in:
Bibliographic Details
Main Authors DE JONG, MARION, VAN HAGEN, PETRUS, MARTINUS, KRENNING, ERIC, PAUL
Format Patent
LanguageEnglish
French
German
Published 01.09.2004
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Use of a peptide compound, which comprises a first peptide part comprising at least once the amino acid sequence Arg-Gly-Asp, and a second peptide part coupled thereto, optionally via a linker, for the manufacture of an agent having biological activity preferably the compound is used for the manufacture of a pharmaceutical agent having an activity related to the affinity for tumors.
Bibliography:Application Number: EP20040101401